Ocumension Therapeutics 1477.HK Stock
Ocumension Therapeutics Price Chart
Ocumension Therapeutics 1477.HK Financial and Trading Overview
| Ocumension Therapeutics stock price | 5.8 HKD |
| Previous Close | 6.98 HKD |
| Open | 6.9 HKD |
| Bid | 6.86 HKD x N/A |
| Ask | 6.9 HKD x N/A |
| Day's Range | 6.76 - 6.98 HKD |
| 52 Week Range | 6.44 - 13.76 HKD |
| Volume | 703.92K HKD |
| Avg. Volume | 670.16K HKD |
| Market Cap | 4.77B HKD |
| Beta (5Y Monthly) | 0.915 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.64 HKD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 13.5 HKD |
1477.HK Valuation Measures
| Enterprise Value | 3.5B HKD |
| Trailing P/E | N/A |
| Forward P/E | -11.694916 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 22.900019 |
| Price/Book (mrq) | 1.6239115 |
| Enterprise Value/Revenue | 16.796 |
| Enterprise Value/EBITDA | -8.263 |
Trading Information
Ocumension Therapeutics Stock Price History
| Beta (5Y Monthly) | 0.915 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 13.76 HKD |
| 52 Week Low | 6.44 HKD |
| 50-Day Moving Average | 7.31 HKD |
| 200-Day Moving Average | 8.25 HKD |
1477.HK Share Statistics
| Avg. Volume (3 month) | 670.16K HKD |
| Avg. Daily Volume (10-Days) | 1.28M HKD |
| Shares Outstanding | 690.71M |
| Float | 259.39M |
| Short Ratio | N/A |
| % Held by Insiders | 40.65% |
| % Held by Institutions | 29.75% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | June 30, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -201.027% |
| Operating Margin (ttm) | -216.85% |
| Gross Margin | 63.10% |
| EBITDA Margin | -203.26% |
Management Effectiveness
| Return on Assets (ttm) | -9.21% |
| Return on Equity (ttm) | -14.68% |
Income Statement
| Revenue (ttm) | 208.12M HKD |
| Revenue Per Share (ttm) | 0.32 HKD |
| Quarterly Revenue Growth (yoy) | 90.10% |
| Gross Profit (ttm) | 102.92M HKD |
| EBITDA | -423028000 HKD |
| Net Income Avi to Common (ttm) | -418376000 HKD |
| Diluted EPS (ttm) | -0.71 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.04B HKD |
| Total Cash Per Share (mrq) | 1.61 HKD |
| Total Debt (mrq) | 24.46M HKD |
| Total Debt/Equity (mrq) | 0.89 HKD |
| Current Ratio (mrq) | 5.479 |
| Book Value Per Share (mrq) | 4.249 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -268708000 HKD |
| Levered Free Cash Flow (ttm) | -418484000 HKD |
Profile of Ocumension Therapeutics
| Country | Hong Kong |
| State | N/A |
| City | Suzhou |
| Address | No. 1858 Yinzhongnan Road |
| ZIP | N/A |
| Phone | N/A |
| Website | https://www.ocumension.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 417 |
Ocumension Therapeutics, together with its subsidiaries, operates as an ophthalmic pharmaceutical platform company in the People's Republic of China. It discovers, develops, and commercializes therapies for ophthalmic patients. The company offers drugs for the treatment of blepharitis, infective and allergic conjunctivitis, dry eye, glaucoma and ocular hypertension, postoperative inflammation, choroidal neovascularization, bacterial conjunctivitis, uveitis, retinitis pigmentosa, acute glaucoma, age-related macular degeneration, cornea graft rejection, myopia, and optic neuritis. It had various drug assets in its portfolio. The company was founded in 2017 and is headquartered in Suzhou, the People's Republic of China.
Q&A For Ocumension Therapeutics Stock
What is a current 1477.HK stock price?
Ocumension Therapeutics 1477.HK stock price today per share is 5.8 HKD.
How to purchase Ocumension Therapeutics stock?
You can buy 1477.HK shares on the HKSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Ocumension Therapeutics?
The stock symbol or ticker of Ocumension Therapeutics is 1477.HK.
Which industry does the Ocumension Therapeutics company belong to?
The Ocumension Therapeutics industry is Biotechnology.
How many shares does Ocumension Therapeutics have in circulation?
The max supply of Ocumension Therapeutics shares is 693.65M.
What is Ocumension Therapeutics Price to Earnings Ratio (PE Ratio)?
Ocumension Therapeutics PE Ratio is now.
What was Ocumension Therapeutics earnings per share over the trailing 12 months (TTM)?
Ocumension Therapeutics EPS is -0.64 HKD over the trailing 12 months.
Which sector does the Ocumension Therapeutics company belong to?
The Ocumension Therapeutics sector is Healthcare.
Ocumension Therapeutics 1477.HK included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| Nasdaq EM Plus Korea Small Cap NQEMKRSCGBP | 1476.35 GBP 1888.16 USD |
<0.01
|
— — | 1476.35 GBP 1888.16 USD | 1476.35 GBP 1888.16 USD | — - | — — |
- {{ link.label }} {{link}}